Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aim: Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for locally advanced rectal cancer achieve a pathological complete response (p CR) while the remainder derive the benefit of improved local control and downstaging and a small proportion show a minimal response. The ability to predict which patients will benefit would allow for improved patient stratification directing therapy to those who are likely to achieve a good response, thereby avoiding ineffective treatment in those unlikely to benefit. Method: A systematic review of the English language literature was conducted to identify pathological factors, imaging modalities and molecular factors that predict p CR following chemoradiotherapy. PubMed, MEDLINE and Cochrane Database searches were conducted with the following keywords and Me SH search terms: ‘rectal neoplasm’, ‘response’, ‘neoadjuvant’, ‘preoperative chemoradiation’, ‘tumor response’. After review of title and abstracts, 85 articles addressing the prediction of p CR were selected. Results: Clear methods to predict p CR before chemoradiotherapy have not been defined. Clinical and radiological features of the primary cancer have limited ability to predict response. Molecular profiling holds the greatest potential to predict p CR but adoption of this technology will require greater concordance between cohorts for the biomarkers currently under investigation. Conclusion: At present no robust markers of the prediction of p CR have been identified and the topic remains an area for future research. This review critically evaluates existing literature providing an overview of the methods currently available to predict p CR to nCRT for locally advanced rectal cancer. The review also provides a comprehensive comparison of the accuracy of each modality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205 · cited 1×
“The management of rectal cancer has evolved over the last 20 years to become multidisciplinary and, for locally advanced tumou rs, may include pre-operative neoadjuvant chemoradiotherapy (n CRT), total mesorectal excision (TME) and adjuvant chemotherapy [1-6].”
BackgroundThe mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
Heald, R. J., Husband, E. M., & Ryall, R. D. H. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800691019 · Cited by 2,917 · cited 1×
“The management of rectal cancer has evolved over the last 20 years to become multidisciplinary and, for locally advanced tumou rs, may include pre-operative neoadjuvant chemoradiotherapy (n CRT), total mesorectal excision (TME) and adjuvant chemotherapy [1-6].”
BackgroundPeeters, K. C. M. J., Marijnen, C. A. M., Nagtegaal, I. D., Kranenbarg, E. K., Putter, H., Wiggers, T., Rutten, H., Pahlman, L., Glimelius, B., Leer, J. W., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000257358.56863.ce · Cited by 1,191 · cited 1×
“The management of rectal cancer has evolved over the last 20 years to become multidisciplinary and, for locally advanced tumou rs, may include pre-operative neoadjuvant chemoradiotherapy (n CRT), total mesorectal excision (TME) and adjuvant chemotherapy [1-6].”
Background
Cited by
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
You, Y. N., Hardiman, K. M., Bafford, A., Poylin, V., Francone, T. D., Davis, K., Paquette, I. M., Steele, S. R., & Feingold, D. L. (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001762 · Cited by 354
Metadata
- Authors
- Ryan, J. E., Warrier, S. K., Lynch, A. C., Ramsay, R. G., Phillips, W. A., & Heriot, A. G.
- Venue
- Colorectal Disease
- Publisher
- Wiley
- Published
- 2016-03
- Volume
- 18
- Issue
- 3
- Pages
- 234-246
- ISSN
- 1462-8910 (ISSN-L)
- 1463-1318
- OpenAlex
- W2566662178
- Cited by
- 172
- References
- 3
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. https://app.cochat.ai/papers/10.1111/codi.13207
- The paper
- Ryan, J. E., Warrier, S. K., Lynch, A. C., Ramsay, R. G., Phillips, W. A., & Heriot, A. G. (2016). Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Disease. https://doi.org/10.1111/codi.13207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.